Resultados de búsqueda para: “search”

[:es]The golden eagle has been hunted and revered by human cultures for thousands of years. Yet this may not have been a uniquely human devotion—Neanderthals, too, may have targeted these impressive birds of prey some 130,000 years ago, according to new research. What’s more, modern humans may have learned their eagle-catching techniques from their hominin…

[:es]Antarctica’s charismatic emperor penguins are thought to be particularly vulnerable to climate change, because warming waters are melting the sea ice where they live and breed. Now, the penguins have abandoned one of their biggest colonies after breeding pairs there failed to raise almost any new chicks in 3 years. Although the move cannot directly…

[:es]Over the past half-century, climate change has been blamed for heat waves, flooding, and rising seas. Now, researchers say warmer temperatures are widening the chasm separating richer and poorer countries, effectively boosting the economies of many wealthy polluters while dampening growth in much of the developing world. As a result, inequality between the haves and…

[:es]From consciousness to cryonics, Nature’s news team answers reader questions about a remarkable piece of research. [:]

[:es]Researchers are narrowing down their measurements of how long the subatomic particle survives on its own. [:]

[:es]Researchers are beginning to understand the ways in which viruses strategically manipulate and cooperate with one another. [:]

[:es]The archaic hominins weren’t homogenous, and archaic humans weren’t shy, research suggests.[:]

[:es]These games combine quantum entanglement, infinity and impossible-to-calculate winning probabilities. But if researchers can crack them, they’ll reveal deep mathematical secrets.[:]

[:es]“Futile”—that’s the devastating label now attached to two highly anticipated clinical trials of a drug that targets β-amyloid, the neuron-killing protein fragment littering the brains of people with Alzheimer’s disease. Biogen in Cambridge, Massachusetts, and Eisai in Tokyo, the pharmaceutical partners developing the drug, called aducanumab, today announced their decision to halt a pair of…